Browse

Slate Medicines announced it will combine with Fulcrum Therapeutics in a reverse merger, giving the struggling biotech a new corporate home. Fulcrum had been developing pociredir, a therapy design…

You might assume Chinese biotechs are enduring sleepless nights worrying about whether the ramping up of rhetoric in the U.S. is putting their new financial gains in peril. But the companies Fierce…